COO
The Cooper Companies, Inc.
59.66
1 x 55.89
2 x 64.55
bid
ask
-
0.72
1.19%
03:45 PM
timesize
Ytd -27.21%
1y -26.75%
59.60
day range
61.01
58.98
52 week range
84.32
Open 60.51 Prev Close 60.38 Low 59.60 High 61.01 Mkt Cap 11.63B
Vol 1.37M Avg Vol 2.12M EPS 2.01 P/E 29.67 Forward P/E 11.85
Beta 0.89 Short Ratio 2.61 Inst. Own 106.78% Dividend N/A Div Yield N/A
Ex Div Date 07-26 Earning 06-04 50-d Avg 68.22 200-d Avg 73.60 1yr Est 91.07
Earning
Date For Estimate Reported Surprise surprise %
2026-06-04 2026-04 1.1 N/A N/A N/A
2026-03-05 2026-01 1.03 1.1 0.07 6.80%
2025-12-04 2025-10 1.11 1.15 0.04 3.60%
2025-08-27 2025-07 1.07 1.1 0.03 2.80%
2025-05-29 2025-04 0.93 0.96 0.03 3.23%
2025-03-06 2025-01 0.92 0.92 N/A N/A
Upgrade / Downgrade
Date Firm Action From To
2026-03-06 Citigroup Upgrade Neutral Neutral
2026-03-06 Barclays Upgrade Overweight Overweight
2026-03-06 Needham Upgrade Buy Buy
2026-02-03 Needham Upgrade Buy Buy
2026-01-26 Barclays Upgrade Overweight Overweight
2025-12-08 Citigroup Upgrade Neutral Neutral
Profile
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Insider Holder
Date Name Relation Quantity Description
2026-01-07 ANDREWS BRIAN G Chief Financial Officer 30.73K Conversion of Exercise of derivative security
2026-03-31 JAY COLLEEN E Director 39.91K Conversion of Exercise of derivative security
2025-03-31 KOZY WILLIAM A Director 31.15K Conversion of Exercise of derivative security
2026-03-31 MADDEN TERESA SMITH Director 15.68K Conversion of Exercise of derivative security
2026-01-07 MCBRIDE DANIEL G Chief Operating Officer 163.85K Conversion of Exercise of derivative security
2026-03-31 RIVAS MARIA Director 14.46K Conversion of Exercise of derivative security
Institution Ownership
Report Date Organization Position Value Percentage
2026-03-30 Blackrock Inc. 16.62M 1.00B 8.52%
2026-03-30 Vanguard Capital Management LLC 12.72M 767.96M 6.52%
2025-12-30 T. Rowe Price Investment Management, Inc. 9.05M 546.26M 4.64%
2025-12-30 State Street Corporation 8.79M 530.97M 4.51%
2026-03-30 Vanguard Portfolio Management LLC 8.72M 526.59M 4.47%
2026-03-30 Capital World Investors 7.41M 447.71M 3.80%
Fund Ownership
Report Date Organization Position Value Percentage
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 6.23M 375.87M 3.19%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard 500 Index Fund 5.01M 302.60M 2.57%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund 4.51M 272.40M 2.31%
2025-12-30 T. Rowe Price Mid-Cap Growth Fund, Inc. 4.27M 258.05M 2.19%
2026-03-30 NEW PERSPECTIVE FUND 3.61M 217.81M 1.85%
2025-12-30 T. Rowe Price Mid-Cap Value Fund, Inc. 3.18M 191.84M 1.63%
Dividend
Dividend Date
0.03 2023-07-27
0.03 2023-07-26
0.03 2023-01-20
0.03 2022-07-26
0.03 2022-01-20
0.03 2021-07-26
Split
Split Date
4 : 1 2024-02-20
2 : 1 2002-11-25
1 : 3 1995-09-22
110 : 100 1983-09-26